Navigation Links
Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect
Date:3/11/2013

Two University of Colorado Cancer Center studies show that the protein receptor Mer is overexpressed in many leukemias, and that inhibition of this Mer receptor results in the death of leukemia cells without affecting surrounding, healthy cells.

The first study, published today in the journal Oncogene, worked with acute myeloid leukemia (AML), for which current chemotherapies offer a cure rate of only about 55 percent.

"In about 2/3 of all AML patients and about 90 percent of adult AML patients, we found that the Mer receptor was upregulated. Mer receptor protein shouldn't exist in normal myeloid cells, but we found it abnormally expressed," says Doug Graham, MD, PhD, investigator at the CU Cancer Center and associate professor of pediatrics and immunology at the University of Colorado School of Medicine.

The Mer receptor sits within the cell membrane, and when it becomes activated the cell receives signals to grow and survive. Leukemia and perhaps many solid cancers have taken advantage of Mer's cell survival function to assist the cancer's rampant proliferation. When Graham and colleagues used shRNA to silence the production of Mer in leukemia cells, they showed decreased leukemia cell survival, increased sensitivity to existing chemotherapies and longer survival in mouse models of leukemia.

A second study, published this month in Blood Cancer Journal, shows similar results with acute lymphoblastic leukemia (ALL), the most common pediatric cancer.

"The ALL cure rate is already over 80 percent, but for patients who relapse, the prognosis is much less optimistic. We need targeted therapies to use as second-line treatments for the population for whom existing therapies aren't lasting, particularly in patients with relapsed T cell ALL," Graham says.

Second, he points out that a quarter of pediatric ALL patients who respond to existing chemotherapies do so at the price of significant long-term si
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related biology news :

1. Temple researchers discover key to heart failure, new therapies on horizon
2. 11th International Congress on Targeted Anticancer Therapies
3. Stem cell breakthrough could lead to new bone repair therapies on nanoscale surfaces
4. Penn Vet study reveals a promising new target for Parkinsons disease therapies
5. Promising new finding for therapies to treat persistent seizures in epileptic patients
6. Researchers discover genetic basis for eczema, new avenue to therapies
7. New technique could make cell-based immune therapies for cancer safer and more effective
8. BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
9. Flu antibody’s one-handed grab may boost effort toward universal vaccine, new therapies
10. Therapies for spinal cord injury: On the cutting edge of clinical translation
11. Aging kidneys may hold key to new high blood pressure therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
(Date:8/20/2015)... Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... joined The Smart Card Alliance and the EMV Migration ... and the Smart Card Alliance Latin America (SCALA) Chapter ... peers and thought leaders promoting adoption of smart card ...
(Date:8/12/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is proud to announce that iMedNet ... technology platform, has led the way to significant and ... 2015.   Q2 2015 and Q1 2015 were, respectively, ... value sold in the company,s 15 year history.  In ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
... is participating in a large-scale, multi-center clinical trial in ... substance, in high doses, can slow the progression of ... million people in the United States. "At present, ... only mask the symptoms they do not alter ...
... have found the "Rosetta Stone" of supervolcanoes, those giant ... massive explosive eruptions that rank among nature,s most violent ... and possibly trigger climatic and environmental effects at ... discovered in the Italian Alps, Sesia Valley by a ...
... 100 billion (1011) neurons, which altogether form about 100 ... mechanism for the generation of this complex wiring pattern ... Hannes Schmidt and Professor Fritz G. Rathjen at the ... have now discovered a molecule that regulates this vital ...
Cached Biology News:Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease? 2'Rosetta Stone' of supervolcanoes discovered in Italian Alps 2'Rosetta Stone' of supervolcanoes discovered in Italian Alps 3MDC researchers discover molecule responsible for axonal branching 2
(Date:8/28/2015)... , ... August 28, 2015 , ... ... Medicine, presented two studies at the International Spine Intervention Society’ s ... 2015 through to August 1st, 2015. With a focus on evidence-based research and ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... for venture capital funds, investment firms and animal health companies to hear from ... raised $160 million. Several have also received licensing agreements or distribution contracts. ...
(Date:8/27/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a ... medicine, today announced that executives from the company will ... September.  , Pedro Lichtinger , ... 17th Annual Global Investment Conference on Wednesday, September 10, ... Hotel in New York City . ...
(Date:8/27/2015)... ... 2015 , ... METTLER TOLEDO's web-based EasyFinder™ tool ... to a manageable shortlist of bench and floor scales and terminals. Specifying a ... with the customer’s industry and application. , Side-by-side product comparisons and an ...
Breaking Biology Technology:Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2METTLER TOLEDO Updates Online Scale Selection Tool 2
... 20 Xennex Inc. (Xennex) announced today that ... has provided Satoris with access to GeneCards(R) and ... to input from the advanced prototype of GeneCards(R) ... development. Satoris is utilizing GeneCards and the related ...
... Photonics , a joint team of researchers at CIC ... de Materiales of CSIC/UPV-EHU in San Sebastian (Spain), Harvard ... in Munich (Germany) reports an innovative method for controlling ... radio-frequency technology. The method opens the door for targeted ...
... has shown that certain marginalized groups including the ... African Americans and Latinos fare worse than others ... injuries and fatalities. , Now, a ... that they also experience greater terrorism-related fears and make ...
Cached Biology Technology:Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions 2Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions 3Bridging the gap in nanoantennas 2Bridging the gap in nanoantennas 3Disabled and other vulnerable groups more susceptible to terrorism fears 2
Request Info...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Contains 0.2 g/L EDTA4Na in phosphate-buffered saline....
Immunochemistry 1 & 2...
Biology Products: